A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant pseudomonas aeruginosa

Michelle K. Rhee, Regis P. Kowalski, Eric G. Romanowski, Francis S. Mah, David C. Ritterband, Y. Jerold Gordon

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Purpose The emergence of ciprofloxacin-resistant Pseudomonas aeruginosa (CRPA) has created a new therapeutic challenge in ophthalmology. We evaluated ophthalmic antibiotics in vitro and in a rabbit keratitis model to determine effective therapy. Design Experimental laboratory investigation. Methods The susceptibilities of 12 CRPA isolates were determined in vitro for amikacin, ceftazidime, tobramycin, polymyxin B, gentamicin, ticarcillin, and the fluoroquinolones (that is, ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin) using E-tests and National Committee of Clinical Laboratory Standards. A rabbit keratitis model was used to determine the reduction in colony counts of CRPA and ciprofloxacin-susceptible P. aeruginosa (CSPA) isolates following topical treatment with polymyxin B/trimethoprim, tobramycin (14 mg/ml), ceftazidime (50 mg/ml), and ciprofloxacin (3 mg/ml). Results For 12 CRPA isolates, the susceptibilities and median minimum inhibitory concentrations ([MIC]μg/ml) were as follows: amikacin (92%, 14.0), ceftazidime (75%, 4.0), tobramycin (67%, 1.75), polymyxin B (42%, 7.0), gentamicin (17%, 7.0), ticarcillin (0%, >32.0), and all fluoroquinolones (0%, >32.0). While no antibiotic regimen reduced colony counts in the time frame of the animal model for CRPA, ciprofloxacin alone demonstrated a significant decrease in colony counts for CSPA. Comparing CRPA with CSPA, both tobramycin and ciprofloxacin demonstrated a significant decrease in colony counts for CSPA. Conclusion Our laboratory studies suggest that current antibiotics may be suboptimal in treating CRPA keratitis. Until new antibiotics are available, combination therapy such as fortified tobramycin and ticarcillin, and others may prove effective in aggressive topical long-term therapy.

Original languageEnglish
Pages (from-to)226-230
Number of pages5
JournalAmerican Journal of Ophthalmology
Volume138
Issue number2
DOIs
StatePublished - Aug 2004
Externally publishedYes

Fingerprint

Dive into the research topics of 'A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant pseudomonas aeruginosa'. Together they form a unique fingerprint.

Cite this